A Prototype Intelligent Hybrid System for Hard Gelatin Capsule Formulation Development
نویسندگان
چکیده
the pharmaceutical industry’s need to maintain its economic incentive to develop new drugs, have required that the industry increase speed to market and reduce the number of failures and overall cost of new drug development. This need has made it imperative for the industry to use efficient, systematic approaches to both drug discovery and formulation design. To accelerate drug discovery, scientists now use highthroughput biological screens and combinatorial chemistry that lead to the rapid discovery and identification of numerous potentially useful drugs. Given this high rate of discovery, drug delivery system development for these drug substances—rather than drug discovery itself—is likely to be the rate-limiting step in getting new drugs to market. Drug substances must be formulated into dosage forms to be practical. These dosage forms must meet the prescribed drug delivery requirements as well as be manufacturable. These requirements present formulation scientists with a complex array of variables. The days of the traditional trial-and-error approach to formulation development based on individual formulators’ experiences are gone, and pharmaceutical scientists must adopt efficient, systematic approaches to keep pace with both the numbers and complexity of new therapeutic substances. Indeed, the challenge to drug delivery has grown significantly in recent years as new, more-potent compounds are being developed that often lack the solubility and permeability characteristics needed for effective oral drug delivery. Capsules occupy a central role in drug development. Because they are perceived to be simpler to manufacture than other oral dosage forms and because of the need to shorten the overall development period, capsules are frequently the first dosage form considered for any orally administered drug, often with the expectation that a compressed tablet will be the final marketed form. Among solid dosage forms, the capsule is second only to the compressed tablet in terms of frequency of use. Given the unique advantages of this dosage form, the popularity of the capsule should not be surprising. For instance, because the medication is contained within the capsule shell, the capsule provides a tasteless, odorless delivery system that doesn’t require a secondary coating step. Many patients find that swallowing capsules is easier than swallowing tablets. Furthermore, several surveys have revealed a generally favorable consumer attitude toward
منابع مشابه
A Hybrid Intelligent System for Formulation of Bcs Class Ii Drugs in Hard Gelatin Capsules
In this paper, we describe a hybrid intelligent system for formulation of BCS Class II drugs in hard gelatin capsules. Several significant challenges are involved in drugformulation: the active ingredients and the fillers in the capsule must be chemically compatible according to biopharmaceutical principles; the formulation must be manufacturable; and it must meet the prescribed drug delivery r...
متن کاملCoden: Ijpnl6 Development and Comparative Evaluation of Theophylline Loaded Extended Release Capsule
The aim of the present study was to develop a new theophylline hard gelatin capsule drug delivery formulation. The formulation have been prepared to enhance its dissolution which could provide better oral absorption of theophylline. Therefore, the effects of the component nature and their proportion in the release rate were investigated. Extended release capsules of theophylline were prepared b...
متن کاملChallenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
The encapsulation of liquids and semi-solids provides solutions for convenient delivery through improved oral absorption of poorly water-soluble drugs. In addition, low dose (content uniformity), highly potent (containment), low melting point drugs, those with a critical stability profile and those for which a delayed release is required are candidates for liquid or semi-solid formulations. Bot...
متن کاملFormulation development for the orexin receptor antagonist almorexant: assessment in two clinical studies
Almorexant, a dual orexin receptor antagonist, was investigated for the treatment of insomnia. The following observations initiated further formulation development: the active pharmaceutical ingredient (API) was sticking to the apparatus used during tablet compression; almorexant has an absolute bioavailability of 11.2%; and almorexant modestly decreased the latency to persistent sleep by 10.4 ...
متن کاملCapsules and It ’ S Technology : an Overview
727 Abstract: The gelatin cap-sule shell may be soft or hard depending on their formulation. Capsules are intended to be swallowed whole by the patient. In instances where patients (especially children) are unable to swallow capsules, the contents of the capsule can be removed and added (e.g., sprinkled) on soft food immediately before ingestion. In the manufacture of pharmaceuticals, encapsula...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2002